Therapeutic Nanocarriers in Cancer Treatment: Challenges and Future Perspective

Targeted Nanocarriers-based Approach For Prostate Cancer Therapy

Author(s): Ashish Garg, Vijay Sagar Madamsetty, Sumel Ashique, Vinod Gauttam and Neeraj Mishra *

Pp: 133-162 (30)

DOI: 10.2174/9789815080506123010008

* (Excluding Mailing and Handling)

Abstract

Prostate cancer is the most common malignancy in men, with elevated morbidity and mortality. The current management, along with dope, leads to chemo defiance. On molecular imaging, many researchers have assisted with staging, restaging, early diagnosis, and, particularly, prostate cancer healing. At the site of cancer, treatment of prostate cancer, including chemo, has encountered many difficulties, such as quick clearance of dope or defiance of drug and short accumulation. Nanotechnology applications and their use in biomedicine to deliver various therapeutic carriers fitted to relieve deputy chemotherapy for cancer treatment. The tumor-targeted dope delivery-related carriers are outlined for prostate cancer healing. Among them, the developing nanotechnology has introduced several innovative new testing technologies, and medications for prostate cancer nanotechnology can significantly increase the management operation of prostate cancer by using specific physical and chemical properties, targeting techniques, or anchoring with imaging / pharmacological substances to provide an innovative theranostics device. This chapter focused on the ultra-modern outgrowth in the observation of nanomaterial and the identity of prostate cancer, including the representation of modes used to point biomolecules operationalization and the various prostate cancers along with nanoparticles, multifunctional nanoplatforms, and nano-related methods of dope delivery in the administration. 


Keywords: Cancer pointing, Chemo, Dope delivery, Nanoparticles, Prostate cancer.

Related Journals
Related Books
© 2024 Bentham Science Publishers | Privacy Policy